Eine Plattform für die Wissenschaft: Bauingenieurwesen, Architektur und Urbanistik
A Macromolecule Reversing Antibiotic Resistance Phenotype and Repurposing Drugs as Potent Antibiotics
In order to mitigate antibiotic resistance, a new strategy to increase antibiotic potency and reverse drug resistance is needed. Herein, the translocation mechanism of an antimicrobial guanidinium‐functionalized polycarbonate is leveraged in combination with traditional antibiotics to afford a potent treatment for drug‐resistant bacteria. Particularly, this polymer–antibiotic combination approach reverses rifampicin resistance phenotype in Acinetobacter baumannii demonstrating a 2.5 × 105‐fold reduction in minimum inhibitory concentration (MIC) and a 4096‐fold reduction in minimum bactericidal concentration (MBC). This approach also enables the repurposing of auranofin as an antibiotic against multidrug‐resistant (MDR) Gram‐negative bacteria with a 512‐fold MIC and 128‐fold MBC reduction, respectively. Finally, the in vivo efficacy of polymer–rifampicin combination is demonstrated in a MDR bacteremia mouse model. This combination approach lays foundational ground rules for a new class of antibiotic adjuvants capable of reversing drug resistance phenotype and repurposing drugs against MDR Gram‐negative bacteria.
A Macromolecule Reversing Antibiotic Resistance Phenotype and Repurposing Drugs as Potent Antibiotics
In order to mitigate antibiotic resistance, a new strategy to increase antibiotic potency and reverse drug resistance is needed. Herein, the translocation mechanism of an antimicrobial guanidinium‐functionalized polycarbonate is leveraged in combination with traditional antibiotics to afford a potent treatment for drug‐resistant bacteria. Particularly, this polymer–antibiotic combination approach reverses rifampicin resistance phenotype in Acinetobacter baumannii demonstrating a 2.5 × 105‐fold reduction in minimum inhibitory concentration (MIC) and a 4096‐fold reduction in minimum bactericidal concentration (MBC). This approach also enables the repurposing of auranofin as an antibiotic against multidrug‐resistant (MDR) Gram‐negative bacteria with a 512‐fold MIC and 128‐fold MBC reduction, respectively. Finally, the in vivo efficacy of polymer–rifampicin combination is demonstrated in a MDR bacteremia mouse model. This combination approach lays foundational ground rules for a new class of antibiotic adjuvants capable of reversing drug resistance phenotype and repurposing drugs against MDR Gram‐negative bacteria.
A Macromolecule Reversing Antibiotic Resistance Phenotype and Repurposing Drugs as Potent Antibiotics
Ding, Xin (Autor:in) / Yang, Chuan (Autor:in) / Moreira, Wilfried (Autor:in) / Yuan, Peiyan (Autor:in) / Periaswamy, Balamurugan (Autor:in) / de Sessions, Paola Florez (Autor:in) / Zhao, Huimin (Autor:in) / Tan, Jeremy (Autor:in) / Lee, Ashlynn (Autor:in) / Ong, Kai Xun (Autor:in)
Advanced Science ; 7
01.09.2020
12 pages
Aufsatz (Zeitschrift)
Elektronische Ressource
Englisch
Environmental pollution by antibiotics and by antibiotic resistance determinants
Online Contents | 2009
|Environmental Antibiotics and Antibiotic Resistance: From Problems to Solutions
Springer Verlag | 2019
|Environmental Antibiotics and Antibiotic Resistance: From Problems to Solutions
Online Contents | 2019
|Environmental pollution by antibiotics and by antibiotic resistance determinants
Online Contents | 2009
|